Target intelligence / Profile preview

Apolipoprotein O pseudogene 2 (APOOP2)

Target: APOOP2
Molecular classification: Other (Pseudogene)

Overview

Apolipoprotein O pseudogene 2 (APOOP2) is a human noncoding DNA sequence that shares significant sequence similarity with the functional apolipoprotein O gene. It does not produce a functional protein, is not expressed as part of any known physiological or pathological process, and is not recognized as a drug target or biomarker. Pseudogenes like APOOP2 are remnants of evolutionary gene duplication or retrotransposition events, lacking any current biological function or relevance to disease or pharmacology[2].

Beyond the preview

Go deeper on Apolipoprotein O pseudogene 2 (APOOP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apolipoprotein O pseudogene 2 (APOOP2).

Explore the full profile